BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33457100)

  • 21. Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin.
    Remark R; Alifano M; Cremer I; Lupo A; Dieu-Nosjean MC; Riquet M; Crozet L; Ouakrim H; Goc J; Cazes A; Fléjou JF; Gibault L; Verkarre V; Régnard JF; Pagès ON; Oudard S; Mlecnik B; Sautès-Fridman C; Fridman WH; Damotte D
    Clin Cancer Res; 2013 Aug; 19(15):4079-91. PubMed ID: 23785047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy.
    Guo L; Wang C; Qiu X; Pu X; Chang P
    Front Immunol; 2020; 11():1052. PubMed ID: 32547556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The consensus immunoscore: toward a new classification of colorectal cancer.
    Lanzi A; Pagès F; Lagorce-Pagès C; Galon J
    Oncoimmunology; 2020 Jul; 9(1):1789032. PubMed ID: 32934885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of long-term survival in patients with stage IV colorectal cancer with multi-organ metastases: a single-center retrospective analysis.
    Miyamoto Y; Hayashi N; Sakamoto Y; Ohuchi M; Tokunagam R; Kurashige J; Hiyoshi Y; Baba Y; Iwagami S; Yoshida N; Yoshida M; Baba H
    Int J Clin Oncol; 2015 Dec; 20(6):1140-6. PubMed ID: 25947545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Impact of the Immune Microenvironment in Spinal Chordoma: Immunoscore as an Independent Favorable Prognostic Factor.
    Zou MX; Lv GH; Wang XB; Huang W; Li J; Jiang Y; She XL
    Neurosurgery; 2019 Jun; 84(6):E318-E333. PubMed ID: 30032257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphological aspects of the hepatic response to neoadjuvant therapy.
    Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
    Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of Metastatic or High-Risk Solid Cancer Patients by Targeting the Immune System and/or Tumor Burden: Six Cases Reports.
    Nicolini A; Ferrari P; Morganti R; Carpi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer.
    Ledys F; Klopfenstein Q; Truntzer C; Arnould L; Vincent J; Bengrine L; Remark R; Boidot R; Ladoire S; Ghiringhelli F; Derangere V
    J Immunother Cancer; 2018 Nov; 6(1):123. PubMed ID: 30454021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization and density of immune cells in the invasive margin of human colorectal cancer liver metastases are prognostic for response to chemotherapy.
    Halama N; Michel S; Kloor M; Zoernig I; Benner A; Spille A; Pommerencke T; von Knebel DM; Folprecht G; Luber B; Feyen N; Martens UM; Beckhove P; Gnjatic S; Schirmacher P; Herpel E; Weitz J; Grabe N; Jaeger D
    Cancer Res; 2011 Sep; 71(17):5670-7. PubMed ID: 21846824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trials.
    Moretto R; Corallo S; Belfiore A; Rossini D; Boccaccino A; Lonardi S; Centonze G; Morano F; Germani MM; Loupakis F; Morelli L; Urbani L; Brich S; Marmorino F; Prisciandaro M; Aprile G; Fassan M; Cillo U; Cattaneo L; Fontanini G; De Braud F; Falcone A; Milione M; Pietrantonio F; Cremolini C
    Eur J Cancer; 2020 Aug; 135():78-88. PubMed ID: 32554314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer.
    Iizasa T; Suzuki M; Yoshida S; Motohashi S; Yasufuku K; Iyoda A; Shibuya K; Hiroshima K; Nakatani Y; Fujisawa T
    Ann Thorac Surg; 2006 Jul; 82(1):254-60. PubMed ID: 16798225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of CTL Infiltration Within the Tumor Microenvironment.
    Church SE; Galon J
    Adv Exp Med Biol; 2017; 1036():33-49. PubMed ID: 29275463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
    Kirilovsky A; Marliot F; El Sissy C; Haicheur N; Galon J; Pagès F
    Int Immunol; 2016 Aug; 28(8):373-82. PubMed ID: 27121213
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancer.
    Inoue Y; Hazama S; Suzuki N; Tokumitsu Y; Kanekiyo S; Tomochika S; Tsunedomi R; Tokuhisa Y; Iida M; Sakamoto K; Takeda S; Ueno T; Yoshino S; Nagano H
    Cancer Sci; 2017 Mar; 108(3):455-460. PubMed ID: 28075526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intratumoral immune microenvironment and survival: the immunoscore].
    Galon J; Bindea G; Mlecnik B; Angell H; Lagorce C; Todosi AM; Berger A; Pagès F
    Med Sci (Paris); 2014 Apr; 30(4):439-44. PubMed ID: 24801041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The consensus Immunoscore in phase 3 clinical trials; potential impact on patient management decisions.
    Pagès F; Taieb J; Laurent-Puig P; Galon J
    Oncoimmunology; 2020 Aug; 9(1):1812221. PubMed ID: 32939329
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EGFR expression variance in paired colorectal cancer primary and metastatic tumors.
    Yarom N; Marginean C; Moyana T; Gorn-Hondermann I; Birnboim HC; Marginean H; Auer RC; Vickers M; Asmis TR; Maroun J; Jonker D
    Cancer Biol Ther; 2010 Sep; 10(5):416-21. PubMed ID: 20595818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.
    Becht E; Giraldo NA; Germain C; de Reyniès A; Laurent-Puig P; Zucman-Rossi J; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH
    Adv Immunol; 2016; 130():95-190. PubMed ID: 26923001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracil.
    Aschele C; Debernardis D; Tunesi G; Maley F; Sobrero A
    Clin Cancer Res; 2000 Dec; 6(12):4797-802. PubMed ID: 11156237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.